Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Raloxifene Hydrochloride × Clear all

NCT00710970 2022-01-24

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

Phase 2 Completed

28 enrolled 8 charts

Urinary Bladder Neoplasms